The adverse effects of chemotherapy on bone mass are not prevented by senolytics
Abstract Cancer survivors experience many short- and long-term side effects caused by chemotherapy, including low bone mineral density and deterioration of bone microarchitecture. Administration of chemotherapy drugs to disease free mice causes rapid bone loss. However, whether the bone effects pers...
Saved in:
| Main Authors: | Md Mohsin Ali, Pilar Simmons, Aaron Warren, Landon B. Gatrell, Ana Resende-Coelho, Taylor McElroy, Antiño R. Allen, Maria Almeida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-01717-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Application of a Senolytic Predictor for Discovery of Novel Senolytic Compounds and Herbs
by: Jinjun Li, et al.
Published: (2025-06-01) -
Targeted delivery of liposomal senolytics to alleviate cellular senescence-induced bone loss
by: Rong Li, et al.
Published: (2025-07-01) -
Modeling treatment of diabetic wounds with oxygen therapy and senolytic drug
by: Nourridine Siewe, et al.
Published: (2025-05-01) -
Senolytic Interventions for Type 2 Diabetes: Current Evidence and Future Directions
by: Selene Sodini, et al.
Published: (2025-06-01) -
A human neuron Alzheimer’s disease model reveals barriers to senolytic translatability
by: Chaska C. Walton, et al.
Published: (2025-07-01)